Subjects with acute coronary syndromes scheduled for cardiac catheterization will be enrolled in this study. Subjects that are to be treated clinically with coronary artery stenting will be randomized to receive a loading dose of clopidogrel versus ticagrelor after diagnostic angiography but prior to stenting. Optical coherence tomography (OCT) will be performed after stenting and the presence of blood clots inside the new stent will be measured and compared between the groups.
Subjects with acute coronary syndromes scheduled for cardiac catheterization will be enrolled in this study. Subjects that are to be treated clinically with coronary artery stenting will be randomized to receive a loading dose of clopidogrel versus ticagrelor after diagnostic angiography but prior to stenting. Optical coherence tomography (OCT) will be performed after stenting and the presence of blood clots inside the new stent will be measured and compared between the groups
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
SINGLE
Subjects are randomized to receive a loading dose of ticagrelor or clopidogrel, and all subjects have Optical Coherence Tomography (OCT) imaging performed at the end of their stenting procedures.
Subjects are randomized to receive a loading dose of ticagrelor or clopidogrel, and all subjects have Optical Coherence Tomography (OCT) imaging performed at the end of their stenting procedures.
Subjects are randomized to receive a loading dose of ticagrelor or clopidogrel, and all subjects have Optical Coherence Tomography (OCT) imaging performed at the end of their stenting procedures.
Massachusetts General Hospital
Boston, Massachusetts, United States
Total thrombus burden as measured by the volume of in-stent thrombus quantified by planimetry.
The total thrombus burden measured on OCT images will be assessed. The volume of in-stent thrombus will be quantified by planimetry.
Time frame: Thrombus burden will be measured at the end of the coronary artery stenting procedure.
PRI (platelet reactivity index) as measured by the PLT-VASP assay.
The extent of platelet inhibition will be measured by PLT-VASP and VerifyNow P2Y12 assays.
Time frame: PRI will be measured at the time of OCT image acquistion (which will occur at the end of the coronary artery stenting procedure).
P2Y12 Reaction Units as measured by the VerifyNow P2Y12 assay.
The extent of platelet inhibition will be measured by PLT-VASP and VerifyNow P2Y12 assays.
Time frame: P2Y12 will be measured at the time of OCT image acquistion (which will occur at the end of the coronary artery stenting procedure).
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.